SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000921895-24-000730
Filing Date
2024-03-28
Accepted
2024-03-28 16:16:55
Documents
2

Document Format Files

Seq Description Document Type Size
1 THE SCHEDULE 13G sc13g12927033_03282024.htm SC 13G 184450
2 JOINT FILING AGREEMENT ex991to13g12927033_03282024.htm EX-99.1 11157
  Complete submission text file 0000921895-24-000730.txt   197356
Mailing Address 485 ROUTE 1 SOUTH BUILDING F, SUITE 320 ISELIN NJ 08830
Business Address 485 ROUTE 1 SOUTH BUILDING F, SUITE 320 ISELIN NJ 08830 6096193990
Outlook Therapeutics, Inc. (Subject) CIK: 0001649989 (see all company filings)

IRS No.: 383982704 | State of Incorp.: DE | Fiscal Year End: 0930
Type: SC 13G | Act: 34 | File No.: 005-89495 | Film No.: 24799184
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address 100 NORTH MAIN STREET SUITE 301 ALPHARETTA GA 30009
Business Address 100 NORTH MAIN STREET SUITE 301 ALPHARETTA GA 30009 646-844-0037
Velan Capital Investment Management LP (Filed by) CIK: 0001848809 (see all company filings)

IRS No.: 844706623 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G